Hormonal and reproductive factors in relation to melanoma in women: Current review and meta-analysis

European Journal of Cancer

Volumn 47, Issue 17, 2011, Pages 2607-2617

  Gandini, Sara ^a   Iodice, Simona ^a   Koomen, Els ^b   Pietro, Alessandra Di ^a   Sera, Francesco ^c   Caini, Saverio ^d  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d ISPO   (Italy)

Author keywords

Education; Hormones; Melanoma; Menarche; Menopause; Meta analysis; Oestrogens; Parity

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

CANCER RISK; FEMALE; FEMALE FERTILITY; HORMONE SUBSTITUTION; HUMAN; MELANOMA; MENARCHE; MENOPAUSE; META ANALYSIS (TOPIC); OBSERVATIONAL STUDY; PARITY; PRIORITY JOURNAL; REPRODUCTION; REVIEW;

AGE FACTORS; CONTRACEPTIVES, ORAL; FEMALE; GONADAL STEROID HORMONES; HORMONE REPLACEMENT THERAPY; HUMANS; INCIDENCE; MELANOMA; MENARCHE; MENOPAUSE; RISK FACTORS; SKIN NEOPLASMS; SOCIOECONOMIC FACTORS;

EID: 80755140153     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2011.04.023     Document Type: Article

References (96)

1. R.C. Conybeare Malignant melanoma and pregnancy: report of 3 cases Obstet Gynecol 24 1964 451 454
2. B.F. Byrd Jr., and W.J. McGamity The effect of pregnancy on the clinical course of malignant melanoma South Med J 47 3 1954 196 200
3. A. Osterlind, M.A. Tucker, B.J. Stone, and O.M. Jensen The Danish case-control study of cutaneous malignant melanoma. III. Hormonal and reproductive factors in women Int J Cancer 42 6 1988 821 824 (Pubitemid 19012906)
4. M.J. Walker, C.W. Beattie, M.K. Patel, S.M. Ronan, and T.K. Das Gupta Estrogen receptor in malignant melanoma J Clin Oncol 5 8 1987 1256 1261
5. P.K. Chaudhuri, M.J. Walker, H.A. Briele, C.W. Beattie, and T.K. Gupta Incidence of estrogen receptor in benign nevi and human malignant melanoma JAMA 244 8 1980 791 793 (Pubitemid 10039256)
6. I. Mogren, H. Stenlund, and U. Hogberg Long-term impact of reproductive factors on the risk of cervical, endometrial, ovarian and breast cancer Acta Oncol 40 7 2001 849 854 (Pubitemid 34082732)
7. J.L. Kelsey, and L. Bernstein Epidemiology and prevention of breast cancer Annu Rev Public Health 17 1996 47 67 (Pubitemid 26146345)
8. D. Grady, and V.L. Ernster Hormone replacement therapy and endometrial cancer: are current regimens safe? J Natl Cancer Inst 89 15 1997 1088 1089 (Pubitemid 27337920)
9. A.H. Eliassen, and S.E. Hankinson Endogenous hormone levels and risk of breast, endometrial and ovarian cancers: prospective studies Adv Exp Med Biol 630 2008 148 165
10. Newcomb PA, Trentham-Dietz A, Hampton JM, et al. Late age at first full term birth is strongly associated with lobular breast cancer. Cancer 2010.
11. G.K. Reeves, K. Pirie, J. Green Million Women Study Collaborators Reproductive factors and specific histological types of breast cancer: prospective study and meta-analysis Br J Cancer 100 3 2009 538 544
12. J.A. Lee, and B.E. Storer Excess of malignant melanomas in women in the British isles Lancet 2 8208-8209 1980 1337 1339 (Pubitemid 11253173)
13. J.A. Lee, and B.E. Storer Further studies on skin melanomas apparently dependent on female sex hormones Int J Epidemiol 11 2 1982 127 131 (Pubitemid 12071055)
14. E. de Vries, S. Houterman, and M.L. Janssen-Heijnen Up-to-date survival estimates and historical trends of cutaneous malignant melanoma in the south-east of the Netherlands Ann Oncol 18 6 2007 1110 1116 (Pubitemid 47050504)
15. L.D. Marrett, H.L. Nguyen, and B.K. Armstrong Trends in the incidence of cutaneous malignant melanoma in New South Wales, 1983-1996 Int J Cancer 92 3 2001 457 462 (Pubitemid 32249726)
16. V. Bataille, and E. de Vries Melanoma - part 1: epidemiology, risk factors, and prevention BMJ 337 2008 a2249
17. E. de Vries, T.E. Nijsten, and O. Visser Superior survival of females among 10, 538 Dutch melanoma patients is independent of Breslow thickness, histologic type and tumour site Ann Oncol 19 3 2008 583 589 (Pubitemid 351325683)
18. H.K. Koh, A.J. Sober, and R.A. Carey Possible association between malignant melanoma and breast cancer Arch Dermatol 123 6 1987 712 713
19. N. Volk, and V. Pompe-Kirn Second primary cancers in breast cancer patients in Slovenia Cancer Causes Control 8 5 1997 764 770 (Pubitemid 27404647)
20. E.B. Harvey, and L.A. Brinton Second cancer following cancer of the breast in Connecticut, 1935-82 Natl Cancer Inst Monogr 68 1985 99 112 (Pubitemid 16233726)
21. Slingluff CL Jr., Reintgen DS, Vollmer RT, Seigler HF. Malignant melanoma arising during pregnancy. A study of 100 patients. Ann Surg 1990;211(5):552-7 [discussion 558-9].
22. R.L. Travers, A.J. Sober, and M. Berwick Increased thickness of pregnancy-associated melanoma Br J Dermatol 132 6 1995 876 883
23. I. Cetin, V. Cozzi, and P. Antonazzo Infertility as a cancer risk factor - a review Placenta 29 Suppl. B 2008 169 177
24. H. Sovino, T. Sir-Petermann, and L. Devoto Clomiphene citrate and ovulation induction Reprod Biomed Online 4 3 2002 303 310
25. M.R. Karagas, T.A. Stukel, and J. Dykes A pooled analysis of 10 case-control studies of melanoma and oral contraceptive use Br J Cancer 86 7 2002 1085 1092 (Pubitemid 34438079)
26. O. Gefeller, K. Hassan, and L. Wille Cutaneous malignant melanoma in women and the role of oral contraceptives Br J Dermatol 138 1 1998 122 124 (Pubitemid 28077949)
27. A. Pfahlberg, K. Hassan, L. Wille, B. Lausen, and O. Gefeller Systematic review of case-control studies: oral contraceptives show no effect on melanoma risk Public Health Rev 25 3-4 1997 309 315 (Pubitemid 28131138)
28. D.F. Stroup, J.A. Berlin, and S.C. Morton Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group JAMA 283 15 2000 2008 2012 (Pubitemid 30214957)
29. R.B. Haynes, M. Kastner, N.L. Wilczynski Hedges Team Developing optimal search strategies for detecting clinically sound and relevant causation studies in EMBASE BMC Med Inform Decis Mak 5 2005 8
30. K.G. Shojania, and L.A. Bero Taking advantage of the explosion of systematic reviews: an efficient MEDLINE search strategy Eff Clin Pract 4 4 2001 157 162
31. S. Greenland Quantitative methods in the review of epidemiologic literature Epidemiol Rev 9 1987 1 30
32. H.C. van Houwelingen, L.R. Arends, and T. Stijnen Advanced methods in meta-analysis: Multivariate approach and meta-regression Stat Med 21 4 2002 589 624 (Pubitemid 34141379)
33. J.P. Higgins, and S.G. Thompson Quantifying heterogeneity in a meta-analysis Stat Med 21 11 2002 1539 1558 (Pubitemid 34746062)
34. S.G. Thompson, and J.P. Higgins How should meta-regression analyses be undertaken and interpreted? Stat Med 21 11 2002 1559 1573 (Pubitemid 34746063)
35. S. Greenland, and M.P. Longnecker Methods for trend estimation from summarized dose-response data, with applications to meta-analysis Am J Epidemiol 135 11 1992 1301 1309
36. P. Macaskill, S.D. Walter, and L. Irwig A comparison of methods to detect publication bias in meta-analysis Stat Med 20 4 2001 641 654 (Pubitemid 32166424)
37. E.R. Koomen, A. Joosse, and R.M. Herings Does use of estrogens decrease the breslow thickness of melanoma of the skin? Oral contraceptives and hormonal replacement therapy Melanoma Res 19 5 2009 327 332
38. D. Zaridze, A. Mukeria, and S. Duffy Risk factors for skin melanoma in Moscow (letter) Int J Cancer 52 1992 159 161
39. M.B. Lens, I. Rosdahl, and A. Ahlbom Effect of pregnancy on survival in women with cutaneous malignant melanoma J Clin Oncol 22 21 2004 4369 4375 (Pubitemid 41185157)
40. A.T. O'Meara, R. Cress, G. Xing, B. Danielsen, and L.H. Smith Malignant melanoma in pregnancy. A population-based evaluation Cancer 103 6 2005 1217 1226 (Pubitemid 40328093)
41. H. Stensheim, B. Moller, T. van Dijk, and S.D. Fossa Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: A registry-based cohort study J Clin Oncol 27 1 2009 45 51
42. M.B. Lens, and M. Dawes Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma Br J Dermatol 150 2 2004 179 185 (Pubitemid 38352453)
43. D. Feskanich, D.J. Hunter, and W.C. Willett Oral contraceptive use and risk of melanoma in premenopausal women Br J Cancer 81 5 1999 918 923 (Pubitemid 29504708)
44. J.P. Vandenbroucke The HRT controversy: observational studies and RCTs fall in line Lancet 373 9671 2009 1233 1235
45. E.A. Holly, R.D. Cress, and D.K. Ahn Cutaneous melanoma in women: ovulatory life, menopause, and use of exogenous estrogens Cancer Epidemiol Biomarkers Prev 3 8 1994 661 668 (Pubitemid 24377959)
46. M.R. Karagas, M.S. Zens, and T.A. Stukel Pregnancy history and incidence of melanoma in women: a pooled analysis Cancer Causes Control 17 1 2006 11 19 (Pubitemid 43083665)
47. M.G. Braem, N.C. Onland-Moret, and P.A. van den Brandt Reproductive and hormonal factors in association with ovarian cancer in the Netherlands cohort study Am J Epidemiol 172 10 2010 1181 1189
48. R.L. Milne, A. Osorio, and T. Ramon y Cajal Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers Breast Cancer Res Treat 119 1 2010 221 232
49. F. Chiaffarino, C. Pelucchi, and F. Parazzini Reproductive and hormonal factors and ovarian cancer Ann Oncol 12 3 2001 337 341 (Pubitemid 32288689)
50. M. Kreuzer, M. Gerken, J. Heinrich, L. Kreienbrock, and H.E. Wichmann Hormonal factors and risk of lung cancer among women? Int J Epidemiol 32 2 2003 263 271 (Pubitemid 36622273)
51. A.K. Kubik, P. Zatloukal, L. Tomasek, and L. Petruzelka Lung cancer risk among Czech women: a case-control study Prev Med 34 4 2002 436 444 (Pubitemid 34971685)
52. A.V. Brenner, Z. Wang, and R.A. Kleinerman Menstrual and reproductive factors and risk of lung cancer among Chinese women, Eastern Gansu province, 1994-1998 J Epidemiol 13 1 2003 22 28 (Pubitemid 44137124)
53. J.K. Paulus, K. Asomaning, and P. Kraft Parity and risk of lung cancer in women Am J Epidemiol 171 5 2010 557 563
54. E. Fernandez, C. La Vecchia, B. D'Avanzo, and E. Negri Menstrual and reproductive factors and pancreatic cancer risk in women Int J Cancer 62 1 1995 11 14
55. B.M. Karlson, J. Wuu, C.C. Hsieh, M. Lambe, and A. Ekbom Parity and the risk of pancreatic cancer: a nested case-control study Int J Cancer 77 2 1998 224 227 (Pubitemid 28287974)
56. N. Kreiger, J. Lacroix, and M. Sloan Hormonal factors and pancreatic cancer in women Ann Epidemiol 11 8 2001 563 567 (Pubitemid 33049891)
57. N.P. Sanchez, M.A. Pathak, and S. Sato Melasma: a clinical, light microscopic, ultrastructural, and immunofluorescence study J Am Acad Dermatol 4 6 1981 698 710 (Pubitemid 11038002)
58. E. Foucar, T.J. Bentley, D.W. Laube, and J. Rosai A histopathologic evaluation of nevocellular nevi in pregnancy Arch Dermatol 121 3 1985 350 354 (Pubitemid 15133755)
59. R.E. Lopez, H. Bhakoo, and N.S. Paolini Effect of estrogen on the growth of B-16 melanoma Surg Forum 29 1978 153 154 (Pubitemid 10111459)
60. C.W. Beattie, S.G. Ronan, and M.S. Amoss Jr. Estrogens influence the natural history of Sinclair swine cutaneous melanoma Cancer Res 51 8 1991 2025 2028
61. P.T. Bradford, D.M. Freedman, A.M. Goldstein, and M.A. Tucker Increased risk of second primary cancers after a diagnosis of melanoma Arch Dermatol 146 3 2010 265 272
62. L. Mellemkjaer, S. Friis, and J.H. Olsen Risk of second cancer among women with breast cancer Int J Cancer 118 9 2006 2285 2292
63. F. Stracci, D. D'Alo, T. Cassetti, M. Scheibel, and F. La Rosa Incidence of multiple primary malignancies in women diagnosed with breast cancer Eur J Gynaecol Oncol 30 6 2009 661 663
64. R.M. MacKie, and D.J. Hole Incidence and thickness of primary tumours and survival of patients with cutaneous malignant melanoma in relation to socioeconomic status BMJ 312 7039 1996 1125 1128 (Pubitemid 26131290)
65. V. Beral, S. Ramcharan, and R. Faris Malignant melanoma and oral contraceptive use among women in California Br J Cancer 36 6 1977 804 809 (Pubitemid 8249819)
66. S.A. Adam, J.K. Sheaves, and N.H. Wright A case-control study of the possible association between oral contraceptives and malignant melanoma Br J Cancer 44 1 1981 45 50 (Pubitemid 11078384)
67. C. Bain, C.H. Hennekens, and F.E. Speizer Oral contraceptive use and malignant melanoma J Natl Cancer Inst 68 4 1982 537 539 (Pubitemid 12078835)
68. E.A. Holly, N.S. Weiss, and J.M. Liff Cutaneous melanoma in relation to exogenous hormones and reproductive factors J Natl Cancer Inst 70 5 1983 827 831 (Pubitemid 13101479)
69. V. Beral, S. Evans, H. Shaw, and G. Milton Oral contraceptive use and malignant melanoma in Australia Br J Cancer 50 5 1984 681 685 (Pubitemid 15211639)
70. C.D. Holman, B.K. Armstrong, and P.J. Heenan Cutaneous malignant melanoma in women: exogenous sex hormones and reproductive factors Br J Cancer 50 5 1984 673 680 (Pubitemid 15211638)
71. A. Green, and C. Bain Hormonal factors and melanoma in women Med J Aust 142 8 1985 446 448 (Pubitemid 15233567)
72. H.O. Adami, I. Persson, R. Hoover, C. Schairer, and L. Bergkvist Risk of cancer in women receiving hormone replacement therapy Int J Cancer 44 5 1989 833 839 (Pubitemid 20007980)
73. R. Zanetti, S. Franceschi, S. Rosso, E. Bidoli, and S. Colonna Cutaneous malignant melanoma in females: the role of hormonal and reproductive factors Int J Epidemiol 19 3 1990 522 526 (Pubitemid 20331794)
74. M.G. Le, P.A. Cabanes, and V. Desvignes Oral contraceptive use and risk of cutaneous malignant melanoma in a case-control study of French women Cancer Causes Control 3 3 1992 199 205
75. J.R. Palmer, L. Rosenberg, and B.L. Strom Oral contraceptive use and risk of cutaneous malignant melanoma Cancer Causes Control 3 6 1992 547 554
76. D. Zaridze, A. Mukeria, and S. Duffy Risk factors for skin melanoma in Moscow Int J Cancer 52 1 1992 159 161
77. I. Persson, J. Yuen, L. Bergkvist, and C. Schairer Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy - long-term follow-up of a Swedish cohort Int J Cancer 67 3 1996 327 332 (Pubitemid 26274121)
78. M.A. Smith, J.A. Fine, R.L. Barnhill, and M. Berwick Hormonal and reproductive influences and risk of melanoma in women Int J Epidemiol 27 5 1998 751 757 (Pubitemid 28504960)
79. J. Westerdahl, H. Olsson, A. Masback, C. Ingvar, and N. Jonsson Risk of malignant melanoma in relation to drug intake, alcohol, smoking and hormonal factors Br J Cancer 73 9 1996 1126 1131 (Pubitemid 26131236)
80. P. Young, D. Purdie, L. Jackman, D. Molloy, and A. Green A study of infertility treatment and melanoma Melanoma Res 11 5 2001 535 541 (Pubitemid 32989441)
81. D.M. Freedman, A. Sigurdson, M.M. Doody, R.S. Rao, and M.S. Linet Risk of melanoma in relation to smoking, alcohol intake, and other factors in a large occupational cohort Cancer Causes Control 14 9 2003 847 857 (Pubitemid 37500736)
82. L. Naldi, A. Altieri, and G.L. Imberti Cutaneous malignant melanoma in women. Phenotypic characteristics, sun exposure, and hormonal factors: a case-control study from Italy Ann Epidemiol 15 7 2005 545 550 (Pubitemid 40982131)
83. M. Vessey, and R. Painter Oral contraceptive use and cancer. Findings in a large cohort study, 1968-2004 Br J Cancer 95 3 2006 385 389 (Pubitemid 44187603)
84. P.C. Hannaford, S. Selvaraj, and A.M. Elliott Cancer risk among users of oral contraceptives: cohort data from the royal college of general practitioner's oral contraception study BMJ 335 7621 2007 651
85. C.S. Lea, E.A. Holly, P. Hartge, and J.S. Lee Reproductive risk factors for cutaneous melanoma in women: a case-control study Am J Epidemiol 165 5 2007 505 513 (Pubitemid 46340552)
86. R.P. Gallagher, J.M. Elwood, and G.B. Hill Reproductive factors, oral contraceptives and risk of malignant melanoma: Western Canada melanoma study Br J Cancer 52 6 1985 901 907 (Pubitemid 16229469)
87. L.A. Brinton, L.J. Melton 3rd, G.D. Malkasian Jr., A. Bond, and R. Hoover Cancer risk after evaluation for infertility Am J Epidemiol 129 4 1989 712 722
88. G. Wyshak, R.E. Frisch, N.L. Albright, T.E. Albright, and I. Schiff Reproductive factors and melanoma of the skin among women Int J Dermatol 28 8 1989 527 530 (Pubitemid 19256558)
89. E.A. Holly, D.A. Aston, and R.D. Cress Cutaneous melanoma in women II. Phenotypic characteristics and other host-related factors Am J Epidemiol 141 1995 934 942
90. M.A. Rossing, J.R. Daling, N.S. Weiss, D.E. Moore, and S.G. Self Risk of cutaneous melanoma in a cohort of infertile women Melanoma Res 5 2 1995 123 127
91. M. Lambe, M. Thorn, P. Sparen, R. Bergstrom, and H.O. Adami Malignant melanoma: reduced risk associated with early childbearing and multiparity Melanoma Res 6 2 1996 147 153 (Pubitemid 26259029)
92. B. Modan, E. Ron, L. Lerner-Geva, and T. Blumstein Cancer incidence in a cohort of infertile women Am J Epidemiol 147 11 1998 1038 1042
93. R.E. Neale, S. Darlington, and M.F. Murphy The effects of twins, parity and age at first birth on cancer risk in Swedish women Twin Res Hum Genet 8 2 2005 156 162 (Pubitemid 40593397)
94. Althuis MD, Scoccia B, Lamb EJ et al. Melanoma, thyroid, cervical, and colon cancer risk after use of fertility drugs. Am J Obstet Gynecol 2005;193(3 Pt 1):668-74.
95. J. Kaae, A. Andersen, H.A. Boyd, J. Wohlfahrt, and M. Melbye Reproductive history and cutaneous malignant melanoma: a comparison between women and men Am J Epidemiol 165 11 2007 1265 1270 (Pubitemid 47234325)
96. C.G. Hannibal, A. Jensen, H. Sharif, and S.K. Kjaer Malignant melanoma risk after exposure to fertility drugs: results from a large Danish cohort study Cancer Causes Control 19 7 2008 759 765